Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 331

The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.

Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy

Open access
Tsiodras, Sotirios, Samonis, George, Boumpas, Dimitrios T., Kontoyiannis, Dimitrios P.·2008·Mayo Clinic Proceedings
DOI 10.1016/s0025-6196(11)60839-2
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0025-6196(11)60839-2

Cites

157 of 157 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 157 references

Research works printed but not linked: 50

  1. Moreland, 2004, Infliximab in rheumatoid arthritis, Curr Rheumatol Rep, 6, 334, 10.1007/s11926-004-0006-3 · doi:10.1007/s11926-004-0006-3
  2. Moreland, 2004, Adalimumab in rheumatoid arthritis, Curr Rheumatol Rep, 6, 333
  3. Braun, 2005, Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis, Ann Rheum Dis, 64, 229, 10.1136/ard.2004.025130 · doi:10.1136/ard.2004.025130
  4. Brandt, 2004, Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-α fusion receptor protein etanercept, J Rheumatol, 31, 531
  5. Brandt, 2001, Infliximab treatment of severe ankylosing spondylitis: one-year followup [letter], Arthritis Rheum, 44, 2936, 10.1002/1529-0131(200112)44:12<2936::AID-ART483>3.0.CO;2-M · doi:10.1002/1529-0131(200112)44:12<2936::aid-art483>3.0.co;2-m
  6. Yamauchi, 2004, The treatment of psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy, and safety, Dermatol Clin, 22, 449, 10.1016/j.det.2003.12.002 · doi:10.1016/j.det.2003.12.002
  7. Strober, 2004, Etanercept for the treatment of psoriasis: combination therapy with other modalities, J Drugs Dermatol, 3, 270
  8. Patel, 2004, Adalimumab: efficacy and safety in psoriasis and rheumatoid arthritis, Dermatol Ther, 17, 427, 10.1111/j.1396-0296.2004.04045.x · doi:10.1111/j.1396-0296.2004.04045.x
  9. Shalaby, 1989, Prevention of the graft-versus-host reaction in newborn mice by antibodies to tumor necrosis factor-α, Transplantation, 47, 1057, 10.1097/00007890-198906000-00028 · doi:10.1097/00007890-198906000-00028
  10. Symington, 1990, Serum tumor necrosis factor α associated with acute graft-versus-host disease in humans, Transplantation, 50, 518, 10.1097/00007890-199009000-00033 · doi:10.1097/00007890-199009000-00033
  11. Srinivasan, 2004, Improved survival in steroid-refractory acute graft versus host disease after non-myeloablative allogeneic transplantation using a daclizumab-based strategy with comprehensive infection prophylaxis, Br J Haematol, 124, 777, 10.1111/j.1365-2141.2004.04856.x · doi:10.1111/j.1365-2141.2004.04856.x
  12. Patriarca, 2004, Infliximab treatment for steroid-refractory acute graft-versus-host disease, Haematologica, 89, 1352
  13. Jacobsohn, 2004, Anti-cytokine therapy for the treatment of graft-versus-host disease, Curr Pharm Des, 10, 1195, 10.2174/1381612043452569 · doi:10.2174/1381612043452569
  14. Yamane, 2003, Infliximab for the treatment of severe steroid refractory acute graft-versus-host disease in three patients after allogeneic hematopoietic transplantation, Leuk Lymphoma, 44, 2095, 10.1080/1042819031000123483 · doi:10.1080/1042819031000123483
  15. Jacobsohn, 2003, Infliximab for steroid-refractory acute GVHD: a case series, Am J Hematol, 74, 119, 10.1002/ajh.10392 · doi:10.1002/ajh.10392
  16. Deepe, 2005, Tumor necrosis factor inhibition and opportunistic infections, Clin Infect Dis, 41, S187, 10.1086/429992 · doi:10.1086/429992
  17. Winthrop, 2004, Tuberculosis cases associated with infliximab and etanercept [letter], Clin Infect Dis, 39, 1256, 10.1086/424460 · doi:10.1086/424460
  18. Liossis, 2005, Monoclonal antibodies and fusion proteins in medicine, J Allergy Clin Immunol, 116, 721, 10.1016/j.jaci.2005.06.035 · doi:10.1016/j.jaci.2005.06.035
  19. Ehlers, 2005, Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept?, Clin Infect Dis, 41, S199, 10.1086/429998 · doi:10.1086/429998
  20. Santora, 2001, Characterization of noncovalent complexes of recombinant human monoclonal antibody and antigen using cation exchange, size exclusion chromatography, and BIAcore, Anal Biochem, 299, 119, 10.1006/abio.2001.5380 · doi:10.1006/abio.2001.5380
  21. Benoit, 2004, Treatment of recalcitrant pustular psoriasis with infliximab: effective reduction of chemokine expression, Br J Dermatol, 150, 1009, 10.1111/j.1365-2133.2004.05960.x · doi:10.1111/j.1365-2133.2004.05960.x
  22. van der Meer, 2005, Side effects of anticytokine strategies [editorial], Neth J Med, 63, 78
  23. Netea, 2003, Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-γ production and Toll-like receptor 4 expression, Arthritis Rheum, 48, 1853, 10.1002/art.11151 · doi:10.1002/art.11151
  24. Deepe, 2005, Modulation of infection with Histoplasma capsulatum by inhibition of tumor necrosis factor-α activity, Clin Infect Dis, 41, S204, 10.1086/429999 · doi:10.1086/429999
  25. Tachibana, 1999, Involvement of CD4+ T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice, Med Mycol, 37, 397, 10.1046/j.1365-280X.1999.00239.x · doi:10.1046/j.1365-280x.1999.00239.x
  26. Carlos, 1994, Disturbances in the production of interleukin-1 and tumor necrosis factor in disseminated murine sporotrichosis, Mycopathologia, 127, 189, 10.1007/BF01102920 · doi:10.1007/bf01102920
  27. van den Brande, 2005, Infliximab induced T lymphocyte apoptosis in Crohn's disease, J Rheumatol Suppl, 74, 26
  28. Mastroianni, 2005, Cytokine profiles during infliximab monotherapy in psoriatic arthritis, Br J Dermatol, 153, 531, 10.1111/j.1365-2133.2005.06648.x · doi:10.1111/j.1365-2133.2005.06648.x
  29. Capsoni, 2005, Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis, Arthritis Res Ther, 7, R250, 10.1186/ar1477 · doi:10.1186/ar1477
  30. Zou, 2002, Immunological basis for the use of TNFα-blocking agents in ankylosing spondylitis and immunological changes during treatment, Clin Exp Rheumatol, 20, S34
  31. Witthoft, 2005, Effectiveness and tolerability of repeated treatment with infliximab in patients with Crohn's disease: a retrospective data analysis in Germany, Int J Colorectal Dis, 20, 18, 10.1007/s00384-004-0645-x · doi:10.1007/s00384-004-0645-x
  32. Singh, 1999, Serious infections in rheumatoid arthritis: relationship to immunosuppressive use, Arthritis Rheum, 42, S242
  33. Lassoued, 2004, Pulmonary aspergillosis in a patient with rheumatoid arthritis treated by etanercept [letter], Clin Exp Rheumatol, 22, 267
  34. Busca, 2007, Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation, Am J Hematol, 82, 45, 10.1002/ajh.20752 · doi:10.1002/ajh.20752
  35. Finn, 2006, Angioinvasive aspergillosis presenting as neutropenic colitis [letter], Histopathology, 49, 440, 10.1111/j.1365-2559.2006.02488.x · doi:10.1111/j.1365-2559.2006.02488.x
  36. Devlin, 2007, Mucormycosis presenting as recurrent gastric perforation in a patient with Crohn's disease on glucocorticoid, 6-mercaptopurine, and infliximab therapy, Dig Dis Sci, 52, 2078, 10.1007/s10620-006-9455-z · doi:10.1007/s10620-006-9455-z
  37. Singh, 2007, Disseminated mucormycosis and orbital ischaemia in combination immunosuppression with a tumour necrosis factor α inhibitor, Clin Experiment Ophthalmol, 35, 275, 10.1111/j.1442-9071.2007.01458.x · doi:10.1111/j.1442-9071.2007.01458.x
  38. Belda, 2004, Systemic candidiasis and infliximab therapy [in Spanish], Gastroenterol Hepatol, 27, 365, 10.1157/13062892 · doi:10.1157/13062892
  39. True, 2002, Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab, J Rheumatol, 29, 1561
  40. Arend, 2004, Cavitating pneumonia after treatment with infliximab and prednisone, Eur J Clin Microbiol Infect Dis, 23, 638, 10.1007/s10096-004-1185-6 · doi:10.1007/s10096-004-1185-6
  41. Chavez-Lopez, 2006, Cerebral cryptococcosis associated with etanercept [in Spanish], Enferm Infecc Microbiol Clin, 24, 288
  42. Hoang, 2007, Localized cutaneous Cryptococcus albidus infection in a 14-year-old boy on etanercept therapy, Pediatr Dermatol, 24, 285, 10.1111/j.1525-1470.2007.00404.x · doi:10.1111/j.1525-1470.2007.00404.x
  43. Ruderman EM, Markenson JA. Granulomatous infections and tumor necrosis factor antagonist therapies. Presented at the Proceedings of the Annual European Congress of Rheumatology EULAR; June 18-21, 2003; Lisbon, Portugal. Abstract THU0209.
  44. Mertz, 2007, Coccidioidomycosis in rheumatology patients: incidence and potential risk factors, Ann N Y Acad Sci, 1111, 343, 10.1196/annals.1406.027 · doi:10.1196/annals.1406.027
  45. Goulet, 2005, Clinical problem solving: the unturned stone, N Engl J Med, 352, 489, 10.1056/NEJMcps041569 · doi:10.1056/nejmcps041569
  46. Jain, 2006, Reactivation histoplasmosis after treatment with anti-tumor necrosis factor α in a patient from a nonendemic area, Respir Med, 100, 1291, 10.1016/j.rmed.2005.09.020 · doi:10.1016/j.rmed.2005.09.020
  47. Sawalha, 2003, Panniculitis: a presenting manifestation of disseminated histoplasmosis in a patient with rheumatoid arthritis, J Clin Rheumatol, 9, 259, 10.1097/01.rhu.0000083606.71931.79 · doi:10.1097/01.rhu.0000083606.71931.79
  48. Khoury, 2004, Fatal case of protothecosis in a hematopoietic stem cell transplant recipient after infliximab treatment for graft-versus-host disease [letter], Blood, 104, 3414, 10.1182/blood-2004-07-2720 · doi:10.1182/blood-2004-07-2720
  49. Vail, 2002, Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area, Transpl Infect Dis, 4, 148, 10.1034/j.1399-3062.2002.01016.x · doi:10.1034/j.1399-3062.2002.01016.x
  50. Roos, 2007, Interstitial pneumonitis and anti-tumor necrosis factor-α therapy [letter], J Rheumatol, 34, 238

Cited by

See all 331

Metadata

Authors
Tsiodras, S., Samonis, G., Boumpas, D. T., & Kontoyiannis, D. P.
Venue
Mayo Clinic Proceedings
Publisher
Elsevier BV
Published
2008-02
Volume
83
Issue
2
Pages
181-194
ISSN
0025-6196 (ISSN-L)
DOI
10.1016/s0025-6196(11)60839-2
OpenAlex
W4254978707
Cited by
331
References
157
FWCI
21.86
Type
journal article
Language
en
Open access
bronze
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy. https://app.cochat.ai/papers/10.1016/s0025-6196(11)60839-2
The paper
Tsiodras, S., Samonis, G., Boumpas, D. T., & Kontoyiannis, D. P. (2008). Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy. Mayo Clinic Proceedings. https://doi.org/10.1016/s0025-6196(11)60839-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.